Products

CAS: 1404 -04-2 Neomycin Powder
CAS: 1404 -04-2 Neomycin Powder

CAS: 1404 -04-2 Neomycin Powder

China CAS: 1404-04-2 Neomycin Powder, Find details about China Neomycin, 1404-04-2 from CAS: 1404-04-2 Neomycin Powder

Model NO.
HNB-Neomycin
Product Name
Neomycin
CAS
1404-04-2
Molecular Weight
614.644
Molecular Formula
C23h52n6o25s3
Density
1.6±0.1 g/cm3
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Appearance
White Powder
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Function
Antibiotic
Payment
Tt/Western Union
Trademark
HNB
Transport Package
Carton Box
Specification
Neomycin 99%
Origin
China
HS Code
3006920000
Model NO.
HNB-Neomycin
Product Name
Neomycin
CAS
1404-04-2
Molecular Weight
614.644
Molecular Formula
C23h52n6o25s3
Density
1.6±0.1 g/cm3
Assay
HPLC99%
Sample
10g Available
Factory Supply
Yes
Appearance
White Powder
Usage
Animal Pharmaceuticals
Shelf Life
2 Years Proper Storage
Certificate
GMP/ISO9001
Packing
Carton Box or Drum
Function
Antibiotic
Payment
Tt/Western Union
Trademark
HNB
Transport Package
Carton Box
Specification
Neomycin 99%
Origin
China
HS Code
3006920000
CAS: 1404-04-2 Neomycin Powder
Cas:1404-04-2 Neomycin powder
product nameNeomycin
cas number1404-04-2
apperancewhite powder
Density1.6±0.1 g/cm3
MFC23H52N6O25S3
MW614.644

An antibiotic, which belongs to the aminoglycoside antibiotic together with streptomycin, kanamycin, and gentamicin. It is produced by Streptomyces freundii; it is effective against both Gram-positive and Gram-negative bacteria. The product is mainly a mixture of neomycin B and C. Neomycin has complete cross-resistance with kanamycin, and partial cross-resistance with streptomycin; similar to similar antibiotics, it has nephrotoxicity and inner ear toxicity, and its damage to the inner ear is often irreversible.
CAS: 1404-04-2 Neomycin Powder
Preparation before colon surgery, as adjuvant treatment when hepatic coma. Neomycin is not suitable for the treatment of systemic infections. This product is not effective against Pseudomonas aeruginosa. Neomycin has a strong antibacterial effect on Mycobacterium tuberculosis, and its minimum inhibitory concentration is generally 0.5mg/ml. Most non-tuberculous mycobacteria are resistant to this product. Neomycin is also effective against many gram-negative bacilli such as Escherichia coli, Klebsiella, Proteus, Enterobacter, Salmonella, Shigella, Brucella, Pasteurella, etc. It has antibacterial effect; Neisseria meningitidis and Neisseria gonorrhoeae are also sensitive to this product. Neomycin has a poor effect on Staphylococcus and other gram-positive cocci. Each group of streptococci, Pseudomonas aeruginosa and anaerobic bacteria are resistant to this product. Neomycin mainly binds to the 30S subunit of bacterial ribosomes and inhibits bacterial protein synthesis. Bacteria can easily develop resistance after contact with neomycin. The combined application of neomycin and other antibacterial drugs or anti-tuberculosis drugs can reduce or delay the development of drug resistance. The product is white or almost white powder.
CAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin Powder
CAS: 1404-04-2 Neomycin PowderCAS: 1404-04-2 Neomycin Powder
 

You Might Also Like